Magnetic subcortical susceptibility is associated with the treatment outcome of repeated ketamine infusion for patients with treatment-resistant depression.

Kengo Yonezawa

[P091] Magnetic subcortical susceptibility is associated with the treatment outcome of repeated ketamine infusion for patients with treatment-resistant depression.

*Kengo Yonezawa¹, Hideaki Tani¹, Shuhei Shibukawa², Yohei Ohtani¹, Kie Nomoto-Takahashi¹, Taisuke Yatomi¹, Shiori Honda¹, Shinsuke Koike², Hiroyuki Uchida¹, Shinichiro Nakajima¹ (1. Keio University School of Medicine, 2. University of Tokyo)

キーワード：Ketamine, Repeat-doses, Treatment-resistant depression, Magnetic Resonance Imaging, Quantitative susceptibility mapping

抄録パスワード認証
抄録の閲覧にはパスワードが必要です。パスワードを入力して認証してください。

講演情報

Depression 1 - Clinical (1)

[P091] Magnetic subcortical susceptibility is associated with the treatment outcome of repeated ketamine infusion for patients with treatment-resistant depression.

パスワード